These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8033439)
1. Use of intravenous immune globulin in newborn infants. Fischer GW Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):73-7. PubMed ID: 8033439 [TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in the prevention and treatment of neonatal bacterial sepsis. Lassiter HA Adv Pediatr; 1992; 39():71-99. PubMed ID: 1442320 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics. Fischer GW; Weisman LE Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview. Fischer GW Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355 [TBL] [Abstract][Full Text] [Related]
5. Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin. Fischer GW; Cieslak TJ; Wilson SR; Weisman LE; Hemming VG J Infect Dis; 1994 Feb; 169(2):324-9. PubMed ID: 8106765 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
7. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review. Fischer GW; Weisman LE; Hemming VG Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S92-7. PubMed ID: 1728993 [TBL] [Abstract][Full Text] [Related]
8. Survival and neutrophil kinetics in infants with severe group B streptococcal disease treated with gamma globulin. Friedman CA; Robbins KK; Temple DM; Miller CJ; Rawson JE J Perinatol; 1996; 16(6):439-42. PubMed ID: 8979181 [TBL] [Abstract][Full Text] [Related]
9. [Current developments in the use of intravenous immunoglobulins]. Bardare M; Dellepiane RM Minerva Pediatr; 1991 Nov; 43(11):665-74. PubMed ID: 1791793 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. DeJonge M; Burchfield D; Bloom B; Duenas M; Walker W; Polak M; Jung E; Millard D; Schelonka R; Eyal F; Morris A; Kapik B; Roberson D; Kesler K; Patti J; Hetherington S J Pediatr; 2007 Sep; 151(3):260-5, 265.e1. PubMed ID: 17719934 [TBL] [Abstract][Full Text] [Related]
11. Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants. Capparelli EV; Bloom BT; Kueser TJ; Oelberg DG; Bifano EM; White RD; Schelonka RL; Pearlman SA; Patti J; Hetherington SV Antimicrob Agents Chemother; 2005 Oct; 49(10):4121-7. PubMed ID: 16189088 [TBL] [Abstract][Full Text] [Related]
12. Vaccination and passive immunisation against Staphylococcus aureus. Schaffer AC; Lee JC Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184 [TBL] [Abstract][Full Text] [Related]
13. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Jenson HB; Pollock BH Pediatrics; 1997 Feb; 99(2):E2. PubMed ID: 9099759 [TBL] [Abstract][Full Text] [Related]
14. Determination of slime-producing S. epidermidis specific antibodies in human immunoglobulin preparations and blood sera by an enzyme immunoassay: correlation of antibody titers with opsonic activity and application to preterm neonates. Lamari F; Anastassiou ED; Stamokosta E; Photopoulos S; Xanthou M; Dimitracopoulos G; Karamanos NK J Pharm Biomed Anal; 2000 Aug; 23(2-3):363-74. PubMed ID: 10933528 [TBL] [Abstract][Full Text] [Related]
19. Specific immune globulin therapy for prevention of nosocomial staphylococcal bloodstream infection in premature infants: not what we hoped for! de la Morena MT J Pediatr; 2007 Sep; 151(3):232-4. PubMed ID: 17719927 [No Abstract] [Full Text] [Related]
20. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections. Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]